Ultra High Potency 1400mg NAD Supplement - NAD Booster Nicotinamide Riboside Supplement - NAD+ Nicotinamide B3 Blend with D-Ribose, Niacin -with RiaGev - 3rd Party Tested (60 Count (Pack of 1)) - Testmarket Special Deals
Deals Trends Proviews Blog
Company
Are you a Seller?
Login Sign up
Ultra High Potency 1400mg NAD Supplement - NAD Boo...

Ultra High Potency 1400mg NAD Supplement - NAD Booster Nicotinamide Riboside Supplement - NAD+ Nicotinamide B3 Blend with D-Ribose, Niacin -with RiaGev - 3rd Party Tested (60 Count (Pack of 1))

Product Details
  • Patented NAD Boosting Formula - Our Ultra High Potency NAD+ Supplement is uniquely formulated with RiaGev, a proprietary blend of D-Ribose and Nicotinamide Ascorbate, clinically proven to boost NAD levels more effectively and efficiently than other NAD boosting ingredients.
  • Enhanced Bioavailability - By delivering the two NAD+ precursors individually in the ideal performance ratio, our supplement not only supports NAD+ production but also ensures optimal absorption and utilization.
  • Setting a New Standard for Purity - To ensure that you are getting the highest-quality product, each batch is tested for quality and purity both during and after manufacturing.
  • Quality, First, and Foremost - Toniiq products are produced in a GMP-certified and NSF-approved state-of-the-art manufacturing facility right here in the USA.
  • Each Batch is Individually Tested - We test each batch both ourselves and through a third-party independent laboratory to ensure our ingredients contain the correct standardized level of purity and active ingredients. We also test each batch for any possible additives, contaminants, and impurities to ensure the highest level of quality.
Promotions
Deals Promotions Deals Promotions Deals Promotions
Promote Your Deals

Coupons, and Products on our website now.

apply now
Deals Promotions Deals Promotions
Explore Products

Coupons, and Products on our website now.

apply now
go top icon

Cookies Policy

We use cookies to improve your browsing experience on our website. By continuing to use this site, you agree to our use of cookies.

Privacy Policy